T-Cell Research
Used to study thymic-dependent T-lymphocyte maturation and immune cell repopulation in immunosuppressed animal models.

Immune Response Studies
Free Shipping on orders over $200
Scan the QR code on any vial to verify its batch, COA, and origin in seconds. Secure traceability from our lab to your bench.
Thymosin Alpha-1 is a peptide made of 28 amino acids. It was first isolated from the thymus, an organ where immune cells mature. It occurs naturally as a fragment of a larger protein called prothymosin alpha. Research has measured how immune cells respond to it, including T cell development and the signals dendritic cells send.
28-amino-acid thymic peptide
The pathways Thymosin Alpha-1 acts on — and what each one does. The animation traces its signal outward from the compound to every target it engages.
T-lymphocyte maturation and differentiation, and the balance of T-cell subsets, are measured in preclinical immunology models following Thymosin Alpha-1.
Research indicates Tα1 signals through Toll-like receptors (notably TLR2 and TLR9) on dendritic cells and monocytes, influencing innate-immune activation and cytokine expression.
In-vitro and animal studies report raised natural-killer-cell activity and a shift toward a Th1 cytokine profile (IFN-γ, IL-2) - endpoints used in antiviral and antitumour immune-response research.
The main areas Thymosin Alpha-1 is being studied for — and the study-reported figures behind them.
Used to study thymic-dependent T-lymphocyte maturation and immune cell repopulation in immunosuppressed animal models.
Investigated in hepatitis and other viral models for its influence on innate and adaptive antiviral immunity.
Studied as an immune adjuvant in preclinical tumour models, with NK and cytotoxic T-cell responses as the measured endpoints.
Examined for modulation of inflammatory cytokine networks and dendritic-cell function in vitro.
An interactive 3D model rendered from the compound record — rotate and explore its structure.
C129H215N33O55
| Strength | 10mg |
| Molecular Formula | C129H215N33O55 |
| Molecular Weight | 3108.29 g/mol |
| Purity | >99% (HPLC) |
| Form | Lyophilized Powder |
| Verified Purity | >99% |
| Quantity | 10mg |
| Appearance | White to off-white powder |
| Stability | 24 months from manufacture date when stored properly |
| Storage | Store at -20°C, protected from light |
Thymosin Alpha-1 (Tα1) is an acetylated 28-amino-acid peptide originally isolated from thymic tissue (thymosin fraction 5). It is a well-characterized immunomodulator studied for its effects on T-cell maturation, Toll-like-receptor signaling, and innate/adaptive immune balance in cell-culture and animal models.
No. Thymosin Alpha-1 is not approved by the FDA for any use in the United States. A synthetic form (thymalfasin) is approved as an immunomodulator in a number of other countries, but this product is supplied strictly as a reference compound for in-vitro laboratory research.
Store the lyophilized powder at −20°C, protected from light; it is stable for approximately 24 months from manufacture. This is storage guidance for the researcher, not a shipping requirement.
Each lot is ≥99% pure by HPLC with identity confirmed by mass spectrometry and ships with third-party analytical documentation of purity, net peptide content, and endotoxin screening.
Not for human or veterinary use. For in-vitro laboratory research only. These statements have not been evaluated by the FDA; this product is not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively to qualified researchers and institutions.